Adenoviral vector vaccine developmentuses engineered adenoviruses to deliver antigen-encoding genes into host cells so that the antigen is produced in a cellular context and presented to the immune system. This platform is valuable because adenoviral particles can stimulate innate immunity, support antigen expression, and promote both antibody and T-cell responses.